Originally published on Fri January 11, 2013 9:29 am
By Scott Hensley
Drugmaker Merck just stuck a fork in a vitamin-based drug to prevent heart disease and stroke.
The company is withdrawing Tredaptive, a long-acting pill combining niacin (No. 3 in the long list of B vitamins) and laropiprant, a chemical that reduces the unpleasant skin flushing caused by high doses of niacin.
An apparent feud between two black market pharmacies has shed light on a shady global industry.
"Rx-Promotion and SpamIt probably are responsible for upward of 50 or 60 percent of spam that you and I got in our inboxes over the last five years," said Brian Krebs, a cyber-security reporter who chronicled the alleged feud on his website. "It's just a ridiculous amount of problems that these two guys cause for everybody."